With production facilities in Denmark, France and Italy, research centres in Denmark and the US and a worldwide sales and distribution reach, Lundbeck has been reimbursing between 2,500 and 3,000 employee expense claims a month during COVID, and expects this to increase to 4,000 post-COVID.
Bettering the lives of people living with brain diseases requires a multifaceted approach. Beyond developing transformative medical therapies, Lundbeck strives to make a difference for patients and supports its employees in this endeavour by smoothing their working practices and administration.
Read the case study to learn how Lundbeck's finance teams have reduced the time taken to administer 72% of claims by 65% and employees are reimbursed within eight days rather than months